GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Umedic Group Bhd (XKLS:0256) » Definitions » Return-on-Tangible-Equity

Umedic Group Bhd (XKLS:0256) Return-on-Tangible-Equity : 10.15% (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Umedic Group Bhd Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Umedic Group Bhd's annualized net income for the quarter that ended in Jan. 2025 was RM7.56 Mil. Umedic Group Bhd's average shareholder tangible equity for the quarter that ended in Jan. 2025 was RM74.49 Mil. Therefore, Umedic Group Bhd's annualized Return-on-Tangible-Equity for the quarter that ended in Jan. 2025 was 10.15%.

The historical rank and industry rank for Umedic Group Bhd's Return-on-Tangible-Equity or its related term are showing as below:

XKLS:0256' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 11.73   Med: 21.89   Max: 45.48
Current: 11.73

During the past 6 years, Umedic Group Bhd's highest Return-on-Tangible-Equity was 45.48%. The lowest was 11.73%. And the median was 21.89%.

XKLS:0256's Return-on-Tangible-Equity is ranked better than
70.05% of 758 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs XKLS:0256: 11.73

Umedic Group Bhd Return-on-Tangible-Equity Historical Data

The historical data trend for Umedic Group Bhd's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Umedic Group Bhd Return-on-Tangible-Equity Chart

Umedic Group Bhd Annual Data
Trend Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Return-on-Tangible-Equity
Get a 7-Day Free Trial 40.62 45.48 18.78 17.88 13.38

Umedic Group Bhd Quarterly Data
Jul19 Jul20 Jul21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.07 9.33 17.32 10.16 10.15

Competitive Comparison of Umedic Group Bhd's Return-on-Tangible-Equity

For the Medical Devices subindustry, Umedic Group Bhd's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Umedic Group Bhd's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Umedic Group Bhd's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Umedic Group Bhd's Return-on-Tangible-Equity falls into.


;
;

Umedic Group Bhd Return-on-Tangible-Equity Calculation

Umedic Group Bhd's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jul. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Jul. 2024 )  (A: Jul. 2023 )(A: Jul. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Jul. 2024 )  (A: Jul. 2023 )(A: Jul. 2024 )
=8.991/( (62.707+71.698 )/ 2 )
=8.991/67.2025
=13.38 %

Umedic Group Bhd's annualized Return-on-Tangible-Equity for the quarter that ended in Jan. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jan. 2025 )  (Q: Oct. 2024 )(Q: Jan. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jan. 2025 )  (Q: Oct. 2024 )(Q: Jan. 2025 )
=7.564/( (73.543+75.434)/ 2 )
=7.564/74.4885
=10.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jan. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Umedic Group Bhd  (XKLS:0256) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Umedic Group Bhd Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Umedic Group Bhd's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Umedic Group Bhd Business Description

Traded in Other Exchanges
N/A
Address
PMT 790, Jalan Cassia Selatan 5/2, Taman Perindustrian Batu Kawan, Pulau Pinang, Bandar Cassia, PNG, MYS, 14110
Umedic Group Bhd is principally involved in the marketing and distribution of various branded medical devices and consumables as well as the provision of after-sales service for all products. The company is also involved in developing, manufacturing, and marketing of medical consumables. It has two reportable segments: marketing and distribution, which includes marketing and distribution of medical devices and the provision of after-sales service; the manufacturing segment includes developing, manufacturing, and marketing of medical devices. The company generates the majority of its revenue from the marketing and distribution segment. The company has customers in Asia Pacific, Americas, Europe, Middle East, Africa, and Oceania geographically.

Umedic Group Bhd Headlines

No Headlines